| 000 | 00997cam a22003255i 4500 | ||
|---|---|---|---|
| 001 | 22488503 | ||
| 003 | SA-PMU | ||
| 005 | 20230831121036.0 | ||
| 008 | 220401s2022 mau 000 0 eng | ||
| 010 | _a 2022935985 | ||
| 020 |
_a9783110739268 _q(hardback) |
||
| 020 |
_z9783110735772 _q(pdf) |
||
| 020 |
_z9783110735819 _q(epub) |
||
| 040 |
_aDLC _beng _erda _cDLC |
||
| 042 | _apcc | ||
| 050 |
_aRS431 _b .B365 2022 |
||
| 245 | 0 | 0 |
_aHeterocyclic anticancer agents / _cBimal Krishna Banik, Bubun Banerjee. |
| 250 | _a1st | ||
| 263 | _a1111 | ||
| 264 | 1 |
_aBoston : _bDe Gruyter, _c2022. |
|
| 300 | _apages cm | ||
| 336 |
_atext _btxt _2rdacontent |
||
| 337 |
_aunmediated _bn _2rdamedia |
||
| 338 |
_avolume _bnc _2rdacarrier |
||
| 700 | 1 |
_aKrishna Banik, Bimal, _eeditor. |
|
| 700 | 1 |
_aBanerjee, Bubun, _eeditor. |
|
| 906 |
_a0 _bibc _corignew _d2 _eepcn _f20 _gy-gencatlg |
||
| 942 |
_2lcc _cBOOK |
||
| 999 |
_c12757 _d12757 |
||